1. Home
  2. HGV vs ABCL Comparison

HGV vs ABCL Comparison

Compare HGV & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hilton Grand Vacations Inc.

HGV

Hilton Grand Vacations Inc.

HOLD

Current Price

$41.98

Market Cap

4.2B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$11.47

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HGV
ABCL
Founded
1992
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.5B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
HGV
ABCL
Price
$41.98
$11.47
Analyst Decision
Hold
Strong Buy
Analyst Count
8
5
Target Price
$52.13
$8.40
AVG Volume (30 Days)
976.7K
9.1M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
97.78
10.91
EPS
0.95
N/A
Revenue
$5,047,000,000.00
$75,128,000.00
Revenue This Year
$25.30
N/A
Revenue Next Year
$1.98
$21.85
P/E Ratio
$44.39
N/A
Revenue Growth
1.33
160.56
52 Week Low
$36.79
$2.75
52 Week High
$55.40
$12.58

Technical Indicators

Market Signals
Indicator
HGV
ABCL
Relative Strength Index (RSI) 36.77 62.27
Support Level $37.46 $3.39
Resistance Level $43.21 $12.58
Average True Range (ATR) 1.36 0.74
MACD -0.14 -0.15
Stochastic Oscillator 16.35 50.77

Price Performance

Historical Comparison
HGV
ABCL

About HGV Hilton Grand Vacations Inc.

Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts and timeshare plans under the Hilton Grand Vacations brand. The company operates in two segments: Real estate sales and financing, and Resort operations and club management. The Real estate sales and financing segment generates revenue from VOI sales and consumer financing, including interest income from loans to members. The Resort operations and club management segment generates revenue from resort management services, club membership fees, and rental of available inventory. The majority of the company's revenue is earned through the Real estate sales and financing segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: